New cannabimimetic indazole derivatives, N-(1-amino-3-methyl-1-oxobutan-2- yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA) and N-(1-amino-3-methyl-1- oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA) identified as designer drugs in illegal products

Forensic Toxicology

Volumn 31, Issue 1, 2013, Pages 93-100

  Uchiyama, Nahoko ^a   Matsuda, Satoru ^a   Wakana, Daigo ^a   Kikura Hanajiri, Ruri ^a   Goda, Yukihiro ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

Designer drug; Illegal product; Indazole derivative; N (1 Amino 3 methyl 1 oxobutan 2 yl) 1 (4 fluorobenzyl) 1H indazole 3 carboxamide (AB FUBINACA); N (1 Amino 3 methyl 1 oxobutan 2 yl) 1 pentyl 1H indazole 3 carboxamide (AB PINACA; Synthetic cannabinoid

Indexed keywords

DESIGNER DRUG; DEUTERIUM; ILLICIT DRUG; INDAZOLE DERIVATIVE; N (1 AMINO 3 METHYL 1 OXOBUTAN 2 YL) 1 (4 FLUOROBENZYL) 1H INDAZOLE 3 CARBOXAMIDE; N (1 AMINO 3 METHYL 1 OXOBUTAN 2 YL) 1 PENTYL 1H INDAZOLE 3 CARBOXAMIDE; UNCLASSIFIED DRUG;

CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICAL STRUCTURE; CONFERENCE PAPER; FLUORESCENCE CORRELATION SPECTROSCOPY; HETERONUCLEAR MULTIPLE QUANTUM COHERENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ION PAIR CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; PROTON TRANSPORT; QUALITATIVE ANALYSIS; ULTRAVIOLET SPECTROSCOPY;

EID: 84872685862     PISSN: 18608965     EISSN: 18608973     Source Type: Journal    
DOI: 10.1007/s11419-012-0171-4     Document Type: Conference Paper

References (19)

1. Kikura-Hanajiri R, Uchiyama N, Kawamura M, Goda Y (2012) Changes in the prevalence of synthetic cannabinoids and cathinone derivatives in Japan. Forensic Toxicol (in press)
2. Kikura-Hanajiri R, Uchiyama N, Kawamura M, Ogata J, Goda Y (2012) Prevalence of new designer drugs and their legal status in Japan (in Japanese with English abstract). Yakugaku Zasshi (in press)
3. EMCDDA (2012) "EMCDDA-Europol 2011 annual report on the implementation of council decision 2005/387/JHA". EMCDDA/Europol, Lisbon. http://www.emcdda.europa.eu/publications/implementation-reports/2011. Accessed April 2012
4. Uchiyama N, Kikura-Hanajiri R, Kawahara N, Haishima Y, Goda Y (2009) Identification of a cannabinoid analog as a new type of designer drug in a herbal product. Chem Pharm Bull 57:439-441
5. Auwärter V, Dresen S, Weinmann W, Müller M, Pütz M, Ferreirós N (2009) 'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs? J Mass Spectrom 44:832-837
6. Uchiyama N, Kikura-Hanajiri R, Kawahara N, Goda Y (2009) Identification of a cannabimimetic indole as a designer drug in a herbal product. Forensic Toxicol 27:61-66
7. EMCDDA (2009) EMCDDA action on new drugs briefing paper: understanding the 'Spice' phenomenon. EMCDDA, Lisbon. http://www.emcdda.europa.eu/ publications/thematic-papers/spice. Accessed April 2010
8. EMCDDA (2011) EMCDDA-Europol 2010 annual report on the implementation of council decision 2005/387/JHA. EMCDDA-Europol, Lisbon. http://www.emcdda.europa. eu/publications/implementation-reports/2010. Accessed April 2012
9. Uchiyama N, Kawamura M, Kikura-Hanajiri R, Goda Y (2011) Identification and quantitation of two cannabimimetic phenylacetylindoles JWH-251 and JWH-250, and four cannabimimetic naphthoylindoles JWH-081, JWH-015, JWH-200, and JWH-073 as designer drugs in illegal products. Forensic Toxicol 29:25-37
10. Nakajima J, Takahashi M, Seto T, Suzuki J (2011) Identification and quantitation of cannabimimetic compound JWH-250 as an adulterant in products obtained via the Internet. Forensic Toxicol 29:51-55
11. Nakajima J, Takahashi M, Seto T, Kanai C, Suzuki J, Yoshida M, Hamano T (2011) Identification and quantitation of two benzoylindoles AM-694 and (4-methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanone, and three cannabimimetic naphthoylindoles JWH-210, JWH-122, and JWH-019 as adulterants in illegal products obtained via the Internet. Forensic Toxicol 29:95-110
12. 35S]GTPγS binding assays. Forensic Toxicol 29:132-141
13. Nakajima J, Takahashi M, Seto T, Yoshida M, Kanai C, Suzuki J, Hamano T (2012) Identification and quantitation of two new naphthoylindole drugs-of-abuse, (1-(5-hydroxypentyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone (AM-2202) and (1-(4-pentenyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone, with other synthetic cannabinoids in unregulated "herbal" products circulated in the Tokyo area. Forensic Toxicol 30:33-44
14. Uchiyama N, Kawamura M, Kikura-Hanajiri R, Goda Y (2012) Identification of two new-type synthetic cannabinoids, N-(1-adamantyl)-1-pentyl-1H-indole-3- carboxamide (APICA) and N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide (APINACA), and detection of five synthetic cannabinoids, AM-1220, AM-2233, AM-1241, CB-13 (CRA-13), and AM-1248, as designer drugs in illegal products. Forensic Toxicol 30:114-125
15. Kneisel S, Bisel P, Brecht V, Broecker S, Müller M, Auwärter V (2012) Identification of the cannabimimetic AM-1220 and its azepane isomer (N-methylazepan-3-yl)-3-(1-naphthoyl)indole in a research chemical and several herbal mixtures. Forensic Toxicol 30:126-134
16. Uchiyama N, Kawamura M, Kikura-Hanajiri R, Goda Y (2012) URB-754: a new class of designer drug and 12 synthetic cannabinoids detected in illegal products. Forensic Sci Int. doi: org/10.1016/j.forsciint.2012.08.047
17. 1 receptor modulators and their preparation and use in treatment of diseases. Patent: WO/2009/106980 September, 2009
18. 1 receptor modulators unflagging work flagging work or and their preparation and use in the treatment of CB1-mediated diseases. Patent: WO/2009/106982 September, 2009
19. 2 receptor binding. Drug Alcohol Depend 60:133-140 (Pubitemid 30625016)